Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research
July 18, 2017
Advanta Immuno-Oncology Gene Expression Assay enables efficient screening of 170 highly informative genes involved in human checkpoint therapeutic response SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expression Assay, an optimized qPCR assay that enables efficient interrogation of tumor immunobiology using proven Fluidigm® microfluidic technology. Designed for [...]
July 18, 2017
SAN DIEGO and MENLO PARK, Calif. -- Novogene, a leading global provider of genomic services and solutions, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, have agreed to jointly develop and promote novel applications based on the PacBio® Sequel® System. New applications developed under this agreement are expected to focus on basic [...]
Acquisition of Oxford Cryosystems Limited by Judges Scientific plc
July 18, 2017
Judges Scientific announces that its majority owned subsidiary Bordeaux Acquisition Limited (“Bordeaux”) has today acquired Oxford Cryosystems Ltd, the global leader in cryogenic devices for X-ray crystallography research. Oxford Cryosystems specialises in the design and manufacture of devices used to cryogenically cool crystalline samples during X-ray crystallography experiments, allowing users to investigate the structure of [...]
Agilent Technologies Presents Thought Leader Award to Dr. Ram Sasisekharan
July 18, 2017
Influential MIT Researcher Recognized for Advancing the Use of Analytical Techniques and Multilayer Analysis for Characterization of Biopharmaceuticals SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Ram Sasisekharan, Ph.D., has received an Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization. A more efficient development of [...]
July 18, 2017
SAN DIEGO -- MyDx, Inc. (OTCQB:MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer initially designed for cannabis professionals and retail consumers to measure the chemicals in cannabis and track their feedback on how each sample is impacting their physiology, today announced that all previously reported variable [...]
QUANTERIX BOOSTS INVESTMENTS IN ITS ACCELERATOR LAB TO SUPPORT RAPID GROWTH OF SIMOA TECHNOLOGY
July 18, 2017
Lexington, Mass. – Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced investments in Quanterix’ state-of-the-art Simoa Accelerator Lab services, including the appointment of Dr. Daniel Sikkema, Ph.D., as Vice President of Accelerator Services. Quanterix’ Simoa technology and its growing Accelerator Lab services are enabling biotechnology [...]
Hans E. Bishop to Join Agilent’s Board of Directors
July 18, 2017
CEO of Juno Therapeutics brings deep knowledge of the biopharma industry SANTA CLARA, Calif. Agilent Technologies, Inc. (NYSE: A) today announced that Hans E. Bishop, CEO of Juno Therapeutics, has been elected to its board of directors. Bishop co-founded Juno Therapeutics, a Seattle-based biopharmaceutical company, in 2013. As president and CEO, Bishop leads Juno as [...]
Avantor Opens New Life Sciences Research Center
July 18, 2017
New Innovation Center in Bridgewater, New Jersey serves as a distinct center of collaboration where Avantor can provide broad contract research capabilities covering gene to protein expression, as well as final formulation and drug delivery CENTER VALLEY, PA --- Avantor®, a global supplier of ultra-high-purity materials for customers across the life sciences and advanced technologies sectors, [...]
Agena Bioscience and Heartgenetics Announce Co-Marketing Alliance
July 18, 2017
HEARTDECODE® Software and Assays Designed for Use with the MassARRAY® DX System San Diego, CA – Agena Bioscience today announced a co-promotion agreement leveraging its MassARRAY® DX clinical diagnostics technology with HeartGenetics’ CE-IVD marked products for cardiovascular testing. The MassARRAY DX, a CE-IVD marked system, provides a streamlined and cost-effective workflow for labs enabling parallel analysis of [...]
ELISA-like Assay for Hyaluronic Acid
July 18, 2017
AMSBIO announces the launch of a new Hyaluronic Acid Quantification Kit, based on a highly specific and tightly binding protein to detect and measure Hyaluronic Acid, also known as Hyaluronan or HA. This product is a competitive ELISA-like kit using a recombinant Hyaluronic Acid Binding Protein (rHABP) optimized to quantify HA polymers of average molecular [...]

